Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia. (Q64951709)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

title

Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Marian L Burr

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Luyi Tian

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Sean Grimmond

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Sarah-Jane Dawson

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Shalin H Naik

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Enid Yi Ni Lam

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Rab K Prinjha

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Mark A. Dawson

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Y-C Chan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Miriam M Yeung

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Dane Vassiliadis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Junwei Shi

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Rhys S Allan

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

author name string

Katie A Fennell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Florian Rambow

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Luis Lara

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Paul Yeh

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Luciano G Martelotto

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Aljosja Rogiers

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Brandon E Kremer

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Olena Barbash

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Helai P Mohammad

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Timothy M Johanson

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Arindam Dhar

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Natalie Karpinich

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Dean S Tyler

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Laura MacPherson

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Nathan Pinnawala

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Chun Yew Fong

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Anthony T Papenfuss

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Ryan G Kruger

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Christopher R Vakoc

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

David L Goode

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Omer Gilan

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Jean-Christophe Marine

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

publication date

20 June 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

published in

Nature Communications

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

page(s)

2723

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

describes a project that uses

2 May 2020

1 reference

10 June 2022

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pmc&rettype=xml&id=6586637

cites work

Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Whole-exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Cancer drug resistance: an evolving paradigm

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

BET inhibitor resistance emerges from leukaemia stem cells

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Tracing the origins of relapse in acute myeloid leukaemia to stem cells.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study).

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

A 17-gene stemness score for rapid determination of risk in acute leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Biology and relevance of human acute myeloid leukemia stem cells

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Chromatin structure and the inheritance of epigenetic information

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

The cancer epigenome: Concepts, challenges, and therapeutic opportunities

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Toward Minimal Residual Disease-Directed Therapy in Melanoma

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

SIRT6 haploinsufficiency induces BRAF melanoma cell resistance to MAPK inhibitors via IGF signalling

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

The cancer stem cell marker aldehyde dehydrogenase is required to maintain a drug-tolerant tumor cell subpopulation

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Modification of enhancer chromatin: what, how, and why?

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

LSD1 inhibition exerts its anti-leukemic effect by recommissioning PU.1- and C/EBPα-dependent enhancers in AML.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Targeting MYC dependence in cancer by inhibiting BET bromodomains

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Click chemistry enables preclinical evaluation of targeted epigenetic therapies.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

GRHL2-Dependent Enhancer Switching Maintains a Pluripotent Stem Cell Transcriptional Subnetwork after Exit from Naive Pluripotency

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Interactome maps of mouse gene regulatory domains reveal basic principles of transcriptional regulation.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Transcription factors: from enhancer binding to developmental control

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

PML/RARalpha targets promoter regions containing PU.1 consensus and RARE half sites in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Essential role of PU.1 in maintenance of mixed lineage leukemia-associated leukemic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Chromatin Scanning by Dynamic Binding of Pioneer Factors

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Genetic determinants and epigenetic effects of pioneer-factor occupancy.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Transcriptional plasticity promotes primary and acquired resistance to BET inhibition

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer Remodeling

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Functional interdependence of BRD4 and DOT1L in MLL leukemia

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Fast and accurate long-read alignment with Burrows-Wheeler transform

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Model-based analysis of ChIP-Seq (MACS)

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Integrative genomics viewer

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

BEDTools: a flexible suite of utilities for comparing genomic features

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

ngs.plot: Quick mining and visualization of next-generation sequencing data by integrating genomic databases

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

MEME-ChIP: motif analysis of large DNA datasets

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

A probability-based approach for the analysis of large-scale RNAi screens.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

HISAT: a fast spliced aligner with low memory requirements

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

HTSeq--a Python framework to work with high-throughput sequencing data

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Haemopedia: An Expression Atlas of Murine Hematopoietic Cells

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

ATAC-seq: A Method for Assaying Chromatin Accessibility Genome-Wide

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Molecular disease monitoring using circulating tumor DNA in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Assessing the clinical value of targeted massively parallel sequencing in a longitudinal, prospective population-based study of cancer patients.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

CEL-Seq2: sensitive highly-multiplexed single-cell RNA-Seq

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

A rapid method to verify single-cell deposition setup for cell sorters

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Pooling across cells to normalize single-cell RNA sequencing data with many zero counts.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

scPipe: A flexible R/Bioconductor preprocessing pipeline for single-cell RNA-sequencing data

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Reproducibility of Illumina platform deep sequencing errors allows accurate determination of DNA barcodes in cells.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Ultrafast and memory-efficient alignment of short DNA sequences to the human genome

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Cancer drug addiction is relayed by an ERK2-dependent phenotype switch

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-10652-9

7 January 2021

Scater: pre-processing, quality control, normalization and visualization of single-cell RNA-seq data in R

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/31222014

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/S41467-019-10652-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31222014%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

PubMed publication ID

31222014

1 reference